"Your Partner of Choice and your gate to the Middle East and North Africa (MENA) Pharmaceutical World"


Genpharm Services is a financially sound privately owned company based in the Dubai Science Park (DSP), U.A.E. We provide fast-track Market Access to specialty pharmaceutical companies looking to expand into the Middle East and North Africa (MENA) region. We focus on innovative and orphan drugs in areas of unmet medical needs, rare genetic disorders and autoimmune diseases.

Pharmaceutical Strategic Advice

"We also provide Management Consultancy for companies aiming at expanding directly into this dynamic region of high growth. We advise on strategies, structures and operating business models in line with the respective company priorities and portfolio. "

Aspire Educational Series: Central Core Disease (CCD) - Part 20

Central core disease (CCD) is a form of muscular dystrophy. It falls under the category of congenital myopathies (which means it’s an inherited condition), in which type 1 skeletal muscle fibers exhibit amorphous area -scores’ that lack mitochondria and oxidative enzyme activity that run the length of the myofibre. Central core disease affects males and females in equal numbers. The exact incidence and prevalence of CCD are unknown. CCD is believed to be the most common form of congenital myopathy, which as a group occurs in 6 out of every 100,000 live births.

His Excellency Sheikh Nahyan bin Mubarak Al Nahyan honoring Genpharm for their role in raising awareness on Rare Diseases and for their contribution on Rare Disease Day

His Excellency Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Culture and the development of knowledge, president of the UAE Genetic Diseases Association, honored several specialized experts in rare diseases, as part of the annual Emirates International Award for reducing genetic diseases "rare disease category" in its third session.

Films from around the world addressing the challenges of life with a rare disease.

The Rare Disease Film Festival is a new event showcasing films from around the world which address the challenges of life with a rare disease. It will be held Oct. 3rd, 2017 in Boston, MA. We believe increased awareness can connect patient families, inspire conversations about translation applications of current science, lead to new paths for research and save lives. These films put the often abstract and dire clinical information into the context of real people living their lives.